Cancer Center Amsterdam
-
Prognostic biomarkers for stage II and III colon cancer
den Uil, S. H., 14 Dec 2023, 160 p.Research output: PhD Thesis › Phd-Thesis - Research and graduation internal
-
High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence
Nugteren, S., den Uil, S. H., Delis-van Diemen, P. M., Simons-Oosterhuis, Y., Lindenbergh-Kortleve, D. J., van Haaften, D. H., Stockmann, H. B. A. C., Sanders, J., Meijer, G. A., Fijneman, R. J. A. & Samsom, J. N., 1 Dec 2022, In: Scientific reports. 12, 1, 12174.Research output: Contribution to journal › Article › Academic › peer-review
-
Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer
den Uil, S. H., de Wit, M., Slebos, R. J. C., Delis-van Diemen, P. M., Sanders, J., Piersma, S. R., Pham, T. V., Coupé, V. M. H., Bril, H., Stockmann, H. B. A. C., Jimenez, C. R., Meijer, G. A. & Fijneman, R. J. A., Feb 2021, In: European Journal of Cancer. 144, p. 91-100 10 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications